Ro 46-2005 structure
|
Common Name | Ro 46-2005 | ||
---|---|---|---|---|
CAS Number | 150725-87-4 | Molecular Weight | 473.542 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 617.5±65.0 °C at 760 mmHg | |
Molecular Formula | C23H27N3O6S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 327.3±34.3 °C |
Use of Ro 46-2005Ro 46-2005 is a novel synthetic non-peptide endothelin receptor antagonist, inhibits the specific binding of 125I-ET-1 to human vascular smooth muscle cells (ETA receptor) with IC50 of 220 nM.IC50 value: 220 nM (ETA) [2]Target: Endothelinin vitro: Ro 46-2005 proves to be equipotent (IC50 200-500 nM) for inhibition of [125I]ET-1 binding on the two known ET receptor subtypes (ETA and ETB). Ro 46-2005 also inhibits the functional consequences of ET-1 stimulation: the ET-l-induced release of arachidonic acid from rat mesangial cells was inhibited with an IC50 of 1.8 μM.[1] |
Name | 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)pyrimidin-4-yl]benzenesulfonamide |
---|---|
Synonym | More Synonyms |
Description | Ro 46-2005 is a novel synthetic non-peptide endothelin receptor antagonist, inhibits the specific binding of 125I-ET-1 to human vascular smooth muscle cells (ETA receptor) with IC50 of 220 nM.IC50 value: 220 nM (ETA) [2]Target: Endothelinin vitro: Ro 46-2005 proves to be equipotent (IC50 200-500 nM) for inhibition of [125I]ET-1 binding on the two known ET receptor subtypes (ETA and ETB). Ro 46-2005 also inhibits the functional consequences of ET-1 stimulation: the ET-l-induced release of arachidonic acid from rat mesangial cells was inhibited with an IC50 of 1.8 μM.[1] |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 617.5±65.0 °C at 760 mmHg |
Molecular Formula | C23H27N3O6S |
Molecular Weight | 473.542 |
Flash Point | 327.3±34.3 °C |
Exact Mass | 473.162048 |
PSA | 128.25000 |
LogP | 2.22 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.593 |
Storage condition | 2-8℃ |
~% Ro 46-2005 CAS#:150725-87-4 |
Literature: Hoffmann-La Roche Inc. Patent: US5292740 A1, 1994 ; US 5292740 A |
Precursor 1 | |
---|---|
DownStream 0 |
Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)-4-pyrimidinyl]- |
N-[6-(2-Hydroxyethoxy)-5-(3-methoxyphenoxy)-4-pyrimidinyl]-4-(2-methyl-2-propanyl)benzenesulfonamide |
Ro 46-2005 |
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)pyrimidin-4-yl]benzenesulfonamide |